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Abstract Reactive oxygen species (ROS) such as superoxide
anions and hydrogen peroxide appear to be transiently produced
in response to growth factor and cytokine stimulation. A variety
of evidence suggests that this ligand-stimulated change in the
cellular redox state participates in downstream signal trans-
duction. This review will focus on the effects of ROS on signal
transduction pathways, the molecules that regulate intracel-
lular ROS production and the potential protein targets of
oxidants. ß 2000 Federation of European Biochemical Socie-
ties. Published by Elsevier Science B.V. All rights reserved.
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1. Oxidants as signaling molecules
The cascade of events triggered by a growth factor or cy-
tokine binding to its cognate receptor has been the subject of
intense scrutiny for the last several decades. In the last several
years it has become increasingly evident that ligand-stimulated
reactive oxygen species (ROS) generation plays a role in the
complex world of signal transduction [1^3]. Analysis of cells
in culture has demonstrated that a variety of ligands including
platelet-derived growth factor (PDGF), epidermal growth fac-
tor (EGF), angiotensin II, as well as a host of cytokines, all
trigger the rapid production of intracellular ROS [4^8].
Following the initial descriptions that certain ligands acti-
vate ROS production, the question remained as to whether
this phenomenon represented a toxic or non-speci¢c response,
or whether the generation of ROS represented an important
element in signaling pathways. Relatively little is known re-
garding the oxidase(s) that may be regulated in a ligand-de-
pendent fashion. As such the initial studies assessing the role
of oxidants in signal transduction have relied on the overex-
pression of antioxidant scavenging proteins or treatment with
chemical scavengers. These initial studies demonstrated that
inhibiting the rise in ROS levels following ligand addition
inhibited a variety of downstream pathways. In particular,
increasing the level of the peroxide scavenging protein catalase
was shown to inhibit the ability of PDGF to stimulate tyro-
sine phosphorylation of a number of proteins [7]. A similar
approach with EGF yielded similar results [6]. This phenom-
enon of redox-dependent signaling is not however limited to
factors that act through tyrosine kinase receptors since angio-
tensin II signal transduction is also a¡ected by redox modu-
lation [9].
2. Regulation of non-phagocytic oxidase(s)
Although these results suggest a role for ROS in a diverse
set of signaling pathways it is important to note that most if
not all of these studies have relied on broad acting antioxi-
dants. As such, it became critical to de¢ne the precise way in
which ligands could activate ROS production. In phagocytic
cells, a variety of stimuli cause the massive release of super-
oxide anion through the assembly of NADPH oxidase. This
multimeric protein complex is essential for neutrophil function
and is composed of both membrane-bound proteins and cy-
tosolic factors [10]. One essential component for assembly of
the neutrophil NADPH oxidase is the small GTPase rac2.
Although rac2 is expressed primarily in phagocytic cells, the
homologous rac1 protein is more ubiquitously expressed.
Consistent with the notion that the rac family of proteins
possess the ability to regulate ligand-stimulated ROS produc-
tion in a variety of cell types is the relatively recent observa-
tion that activating mutants of rac1 stimulate ROS produc-
tion in ¢broblasts and other non-phagocytic cell types [8,11^
14]. Similarly, expression of the dominant negative form of
rac1 in non-phagocytic cells appears to inhibit ROS produc-
tion following stimulation by a variety of di¡erent ligands
[8,11]. Interestingly, the ability of rac proteins to contribute
to ras-mediated transformation appears in part related to
their ability to produce superoxide anions [12,13]. In partic-
ular, site-directed mutants of rac that speci¢cally inhibit
superoxide production fail to stimulate DNA synthesis [13].
The ability of rac to regulate superoxide production in both
phagocytic and non-phagocytic cells suggests that non-phag-
ocytic cells may have a molecular oxidase complex similar to
the NADPH oxidase of neutrophils. This is supported by
biochemical studies suggesting NADPH/NADH oxidase ac-
tivity can be detected in a variety of cell lysates [15]. Although
many components of the NADPH oxidase are ubiquitously
expressed, the major cytochrome, gp91, appears unique to
phagocytes. Nonetheless, two recent reports have revealed a
homologue of gp91 that is expressed in non-phagocytic cells
[16,17]. Evidence suggests that this protein might participate
in growth regulation [16]. This suggests that similar to neu-
trophils, non-phagocytic cells appear to have a rac-regulated
NADPH oxidase complex that produces ROS in response to a
host of ligands. In many ways this suggests that analogous to
another oxidant, nitric oxide, superoxide (and/or hydrogen
peroxide) can be produced in immune e¡ector cells in large
quantities and in non-phagocytic cells in much smaller quan-
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tities. In immune cells, large scale production of NO by mac-
rophages, or superoxide by neutrophils, provides a necessary
host defense function, while when produced in smaller doses
in non-phagocytic cells, these same reactive molecules func-
tion as signaling molecules. For both NO and superoxide, the
complexes responsible for large scale immunological and
smaller scale signaling functions represent homologous but
distinct enzyme systems. In the case of NO, there are the
inducible versus the constitutive nitric oxide synthase en-
zymes, while for the case of superoxide there appear to be
the two similar, but structurally distinct, NADPH oxidase
systems.
3. Mechanism of oxidant signaling
Although the above sets of experiments implicate ROS as
mediators of growth factor signal transduction, relatively little
is known regarding the speci¢c mechanism through which
oxidants act. In particular, given the exquisite nature of sig-
naling pathways it would seem likely that once generated,
ROS must in some way intersect with the known and well
established pathways governing cell growth. This would sug-
gest that oxidants may have direct protein targets wherein
exposure of these proteins to an altered redox state alters
the function of the target protein. Some recent evidence sup-
ports this notion and suggests that both certain protein^pro-
tein interactions and enzymatic function might be regulated
by cellular ROS levels.
One piece of evidence linking the cellular redox state to
speci¢c signaling pathways came from the analysis of a yeast
two-hybrid screen using apoptosis signal-regulated kinase 1
(ASK1) as bait. ASK1 is a member of the family of mito-
gen-activated protein kinase kinase kinases that is involved
in the activation of stress-activated protein kinases (SAPK
or c-Jun NH2-terminal kinases) and p38 kinase. Interestingly,
thioredoxin, an antioxidant protein, was found to form a
complex with ASK1. When thioredoxin is complexed to
ASK1, the activity of ASK1 is inhibited [18]. The rise in
ROS levels that occurs following tumor necrosis factor stim-
ulation resulted in the dissociation of ASK1 from thioredoxin
and the subsequent activation of ASK1 activity [18,19]. As
such, thioredoxin can be thought of as both an antioxidant
protein and a redox sensor. It is unlikely that this dual func-
tion is unique for thioredoxin and as such the concept of
antioxidant proteins functioning only as free £oating ROS
scavengers may need to be revised. Indeed it is possible that
other antioxidant proteins such as the periredoxin family [20]
will also be shown to interact with speci¢c intracellular signal-
ing molecules and regulate their activity in a redox-dependent
fashion. Interestingly, also consistent with this notion, pre-
vious studies have determined that superoxide dismutase
(Sod1) can interact and regulate calcineurin activity [21].
Another way that changes in ROS can alter signaling path-
ways is by speci¢cally altering the oxidation of reactive cys-
teine residues in proteins. Under physiological conditions,
most cysteines in protein are in the protonated (SH) form.
In certain proteins, certain cysteines have their sulfhydryl
group oxidized at physiological pH. The exact basis for for-
mation of what is termed a reactive cysteine is presently un-
clear although it appears to require the contribution of pos-
itive charges from neighboring amino acids. Perhaps the best
characterized reactive cysteine is found in the bacterial tran-
scription factor OxyR whose activity is sensitive to the redox
state [22]. Nonetheless, a variety of proteins in mammalian
cells have been demonstrated to contain reactive cysteines.
From a signaling point of view perhaps the most relevant is
the family of proteins that act as protein tyrosine phospha-
tases. All members of this family have a reactive cysteine in
their active site and it has been appreciated for some time that
oxidant stress can reversibly inactivate cellular tyrosine phos-
phatase activity. The mechanism for transient inactivation
presumably involves oxidation of the reactive cysteine to
form a sulfenic ion. In this form, the enzymatic activity of
the phosphatase (or potentially other enzymes) is signi¢cantly
reduced or abolished. The oxidized reactive cysteine now in
the sulfenic form is most likely capable of interacting with
cellular glutathione to form a protein mix disul¢de. This
mix disul¢de can be reduced probably through the actions
of cellular enzymes such as glutaredoxin or thioredoxin to
restore the original molecule. While continued high levels of
oxidant stress could lead to irreversible oxidized states above
sulfenic acid (i.e. creation of a sul¢nic ion), the scheme dia-
gramed in Fig. 1 represents a speci¢c, reversible mechanism
for regulation of enzyme activity by oxidant stress. In this
scenario, speci¢city comes from the local amino acid environ-
ment surrounding the cysteine residue that leads to its reac-
tivity. In many ways this is analogous to amino acid motifs in
Fig. 1. Proposed pathway for signal transduction by reactive cys-
teine modi¢cation. Most cysteine residues in proteins are fully re-
duced at physiological pH, however, certain reactive cysteine resi-
dues, most likely due to the contribution of positive charges from
neighboring amino acids, can be readily oxidized at pH 7 or below.
Further oxidation leads to the formation of a sulfenic ion and in
the case of tyrosine phosphatases to a corresponding reduction in
enzymatic activity. Continued high levels of oxidant stress would
lead to further and most likely irreversible oxidation to a sul¢nic
ion. In contrast, the sulfenic ion formed by mild oxidative stress
can be reduced back to S3. Given the presence of millimolar gluta-
thione (GSH) inside cells, one likely pathway for reduction would
involve the formation of a protein mix disul¢de. These protein mix
disul¢des could then in turn be substrates for enzymes such as thio-
redoxin (Trx) or glutaredoxin (Grx) to return the reactive cysteine
to its basal state. Such a pathway would allow for the transient,
speci¢c and reversible modi¢cation of enzymatic activity in proteins
with a reactive cysteine. In many ways, this is analogous to the way
phosphorylation of speci¢c amino acids regulates enzymatic activity.
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other proteins surrounding speci¢c serine, threonine or tyro-
sine residues that serve as recognition for phosphorylation by
cellular kinases. In both cases, enzymatic activity is regulated
in a reversible fashion by targeting speci¢c amino acids using
either phosphate addition for the well characterized protein
phosphorylation or cysteine oxidation/glutathione addition
for redox signaling.
Evidence is slowly emerging that ligand-stimulated ROS
production may be su⁄cient to regulate the speci¢c activity
of certain protein targets. Analysis of the protein tyrosine
phosphatase 1B (PTP-1B) following EGF stimulation suggests
a temporary inactivation of phosphatase activity that corre-
sponds temporally with the burst of ROS production [23].
Interestingly, analysis of PTP-1B reactive cysteine moiety fol-
lowing EGF stimulation demonstrates a transient glutathiola-
tion of PTP-1B at the peak of ROS production [24]. This
suggests that the covalent addition of glutathione to reactive
cysteines may be one mechanism for achieving reversible re-
dox-dependent signaling as well as a potential means for iden-
tifying relevant redox-dependent signaling molecules.
In summary, emerging evidence suggests the participation
of reactive oxygen species as a component of signal transduc-
tion for a wide host of growth factors and cytokines. Further
studies are needed to de¢ne the exact chemical nature of the
relevant ROS involved in signal transduction, the enzymatic
intracellular source of ligand-stimulated ROS and the speci¢c
protein targets of oxidants. Given that oxidant stress appears
to contribute to a variety of human diseases, it seems likely
that the information learned from probing oxidant signaling
will provide insight into a wide variety of physiological and
pathophysiological conditions.
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